Association between body weight variability and incidence of Parkinson disease: A nationwide, population-based cohort study

被引:7
作者
Park, Joo-Hyun [1 ]
Choi, Yeonjoo [1 ]
Kim, Hyunjin [1 ]
Nam, Myung Ji [1 ]
Lee, Chung-woo [1 ]
Yoo, Ji Won [2 ]
Jung, Jin-Hyung [3 ]
Park, Yong-Gyu [3 ]
Han, Kyungdo [4 ]
Kim, Do-Hoon [1 ]
机构
[1] Korea Univ, Coll Med, Ansan Hosp, Dept Family Med, Ansan, South Korea
[2] Univ Nevada, Dept Internal Med, Sch Med, Las Vegas, NV 89154 USA
[3] Catholic Univ Korea, Dept Biostat, Coll Med, Seoul, South Korea
[4] Soongsil Univ, Dept Stat & Actuarial Sci, 369 Sangdo Ro, Seoul 06978, South Korea
关键词
body mass index; body weight variability; Parkinson disease; QUALITY-OF-LIFE; MASS INDEX; RISK; PROTECTS; GHRELIN; OBESITY;
D O I
10.1111/ene.15025
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose Although body weight variability has been associated with mortality, cardiovascular disease, and dementia, the relationship between body weight variability and Parkinson disease (PD) has rarely been studied. We aimed to investigate the longitudinal association between body weight variability and PD incidence. Methods A nationwide population-based, cohort study was conducted using the database from the Health Insurance Review and Assessment Service of the whole Korean population. We analyzed 2,815,135 participants (>= 40 years old, mean age = 51.7 +/- 8.6 years, 66.8% men) without a previous PD diagnosis. We determined individual body weight variability from baseline weight and follow-up visits. We used Cox proportional hazards regression models. Results The highest quartile group was associated with increased PD incidence compared with the lowest quartile group after adjustment for confounding factors (hazard ratio [HR] = 1.18, 95% confidence interval [CI] = 1.08-1.29). In contrast, baseline body mass index, baseline waist circumference, and waist circumference variability were not associated with increased PD incidence. In the body weight loss group, individuals within the quartile of the highest variation in body weight showed a higher HR of PD risk than those within other quartiles (HR = 1.41, 95% CI = 1.18-1.68). Conclusions Body weight variability, especially weight loss, was associated with higher PD incidence. This finding has important implications for clinicians and supports the need for preventative measures and surveillance for PD in individuals with fluctuating body weight.
引用
收藏
页码:3626 / 3633
页数:8
相关论文
共 26 条
[1]   Midlife adiposity and the future risk of Parkinson's disease [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Nelson, JS ;
Masaki, KH ;
Tanner, CM ;
Curb, JD ;
Blanchette, PL ;
Popper, JS ;
Petrovitch, H .
NEUROLOGY, 2002, 59 (07) :1051-1057
[2]   Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism [J].
Andrews, Zane B. ;
Erion, Derek ;
Beiler, Rudolph ;
Liu, Zhong-Wu ;
Abizaid, Alfonso ;
Zigman, Jeffrey ;
Elsworth, John D. ;
Savitt, Joseph M. ;
DiMarchi, Richard ;
Tschoep, Matthias ;
Roth, Robert H. ;
Gao, Xiao-Bing ;
Horvath, Tamas L. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (45) :14057-14065
[3]   Body-Weight Fluctuations and Outcomes in Coronary Disease [J].
Bangalore, Sripal ;
Fayyad, Rana ;
Laskey, Rachel ;
DeMicco, David A. ;
Messerli, Franz H. ;
Waters, David D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14) :1332-1340
[4]   Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection [J].
Bayliss, Jacqueline A. ;
Andrews, Zane B. .
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2013, 4 (01) :25-36
[5]   Obesity and the risk of Parkinson's disease [J].
Chen, HL ;
Zhang, SMM ;
Schwarzschild, MA ;
Hernán, MA ;
Willett, WC ;
Ascherio, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (06) :547-555
[6]   Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 [J].
Dorsey, E. R. ;
Constantinescu, R. ;
Thompson, J. P. ;
Biglan, K. M. ;
Holloway, R. G. ;
Kieburtz, K. ;
Marshall, F. J. ;
Ravina, B. M. ;
Schifitto, G. ;
Siderowf, A. ;
Tanner, C. M. .
NEUROLOGY, 2007, 68 (05) :384-386
[7]   Body mass index and the risk of Parkinson disease [J].
Hu, G. ;
Jousilahti, P. ;
Nissinen, A. ;
Antikainen, R. ;
Kivipelto, M. ;
Tuomilehto, J. .
NEUROLOGY, 2006, 67 (11) :1955-1959
[8]   The Future of Research in Parkinson Disease [J].
Jankovic, Joseph ;
Sherer, Todd .
JAMA NEUROLOGY, 2014, 71 (11) :1351-1352
[9]   Parkinson's disease [J].
Kalia, Lorraine V. ;
Lang, Anthony E. .
LANCET, 2015, 386 (9996) :896-912
[10]   Polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in the general population in Finland [J].
Kiviranta, H ;
Tuomisto, JT ;
Tuomisto, J ;
Tukiainen, E ;
Vartiainen, T .
CHEMOSPHERE, 2005, 60 (07) :854-869